The global osteoporosis therapeutics market stands at a valuation of US$ 12.7 Bn currently, and is predicted to reach US$ 14.2 Bn by the end of 2026. Market Overview Osteoporosis is a condition characterized by weakened bones, increasing the risk of fractures. It predominantly affects the elderly, particularly postmenopausal women, due to the decline in estrogen, a hormone that protects bone...